期刊文献+

载脂蛋白M基因启动子的克隆及荧光素酶报告基因载体的构建

Cloning of ApoM gene promoter and constructing of luciferase report gene vector
下载PDF
导出
摘要 目的为深入研究载脂蛋白M(ApoM)基因的表达调控机制,对ApoM基因启动子序列进行克隆,并构建不同长度启动子荧光素酶报告基因载体。方法在NCBI人类基因组数据库中截取并下载ApoM基因转录起始位点5’侧翼区约2kb的基因组序列设计PCR扩增引物,从健康外周血中扩增获得该片段,以此序列为基础进行亚克隆,分别获得6条5’端不等、3’端平齐的片段,最后插入pGL3-Basic表达载体。结果获得了6条长度差别约为200bpApoM启动子片段,并构建了不同长度的pGL3-ApoM真核表达载体。结论上述载体的成功构建及序列分析为进一步研究ApoM基因的启动子活性及基因表达调控奠定了基础。 Objective To construct luciferase report gene vector for ApoM gene promoter in order to provide foundation for further study on the possible regulation mechanism of ApoM gene expression. Methods A 2 kb DNA sequence of ApoM 5' end was obtained from NCBI by BLAST software. 6 different long target sequences from a heahhy blood donor DNA sample were amplified by PCR amplification,then the products were identified by DNA sequencing. The ApoM promoter subclone fragments were inserted into the pGLB-basic vector. Results The 6 identified ID4 promoter sequences with an interval of approximate 200 bp were successfully cloned and 6 sub-ApoM promoter- pGL3 basic recombinants were constructed. Conclusion These results may make an important basis for the further study of ApoM promoter activity and regulation of gene expression.
出处 《中国医药科学》 2013年第11期30-32,共3页 China Medicine And Pharmacy
基金 贵阳医学院国家级教学团队专项基金(0703003)
关键词 载脂蛋白M基因 启动子 荧光素酶报告基因 构建 ApoM gene Promoter Luciferase report gene vector Construction
  • 相关文献

参考文献11

二级参考文献49

  • 1胡培丽,岳秉飞.单核苷酸多态性的研究进展[J].实验动物科学与管理,2006,23(1):36-38. 被引量:7
  • 2[1]BARTER P,RYE K.Molecular mechanisms of reverse cholesterol transport[J].Curr Opin Lipidol,1996,7:82-87.
  • 3[2]FORTE T,McCALL M.The role of apolipoprotein A-I-containing lipoproteins in atherosclerosis[J].Curr Opin Lipidol,1994,5:354-364.
  • 4[3]REARDON M,NESTEL P,CRAIG I,et al.Lipoprotein predictors of the severity of coronary artery disease in men and women[J].Circulation,1985,71:881-888.
  • 5[4]ZHENG X Y,DONG X,ZHENG L,et al.Specific tissue ecperssion and cellular localization[J].Acta Histochemical,2003,105:67-72.
  • 6[5]FRANCIS M C,FRANCIS J J.Coronary artery disease in patients at low risk-apolipoprotein AI as an independent risk factor[J].Atherosclerosis,2001,155:165-170.
  • 7[6]XU N,DAHLBACK B.A novel human apolipoprotein (ApoM)[J].J Biol Chem,1999,274:31286-31290.
  • 8Xu N, Dahl back B. A novel human apotipoprotein(apoM) [J]. J BiolChem,1999, 274(44): 31 286-290.
  • 9Christoffersen C, Nielsen LB, Olof Axler, et al. Isolation and characterization of human apolipoprotein M - contai- ning lipoproteins[ J]. J Lipid Res, 2006, 47 : 1 833-843.
  • 10Zhang B, Bai H, Liu R, et al. Serum high-density lipopro- rein-cholesterol levels modify the association between plas- ma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men [ J ]. Metabolism, 2004, 53: 423-429.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部